| Enhancing Molecular Design through Graph-based Topological Reinforcement Learning | Nov 22, 2024 | Drug DesignDrug Discovery | —Unverified | 0 |
| Enhancing Solution Efficiency in Reinforcement Learning: Leveraging Sub-GFlowNet and Entropy Integration | Oct 1, 2024 | Computational EfficiencyDiversity | —Unverified | 0 |
| Evaluation of GPT and BERT-based models on identifying protein-protein interactions in biomedical text | Mar 30, 2023 | Drug DesignLiterature Mining | —Unverified | 0 |
| Evolutionary Multi-Objective Design of SARS-CoV-2 Protease Inhibitor Candidates | May 6, 2020 | Drug Design | —Unverified | 0 |
| Explainable Machine Learning and Deep Learning Models for Predicting TAS2R-Bitter Molecule Interactions | Jun 21, 2024 | Drug DesignExplainable Models | —Unverified | 0 |
| Exploring Gene Regulatory Interaction Networks and predicting therapeutic molecules for Hypopharyngeal Cancer and EGFR-mutated lung adenocarcinoma | Feb 27, 2024 | Drug Design | —Unverified | 0 |
| Extracting Interpretable Logic Rules from Graph Neural Networks | Mar 25, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Learning to Detect Critical Nodes in Sparse Graphs via Feature Importance Awareness | Dec 3, 2021 | Drug DesignFeature Importance | —Unverified | 0 |
| Federated Discrete Denoising Diffusion Model for Molecular Generation with OpenFL | Jan 21, 2025 | DenoisingDrug Design | —Unverified | 0 |
| FfDL : A Flexible Multi-tenant Deep Learning Platform | Sep 14, 2019 | Deep LearningDrug Design | —Unverified | 0 |
